French insurance group AXA has prevailed in a protracted legal battle in London’s High Court against Santander, securing a ruling worth approximately £675 million relating to the long-running UK payment protection insurance (PPI) scandal.
The dispute centred on PPI policies that were underwritten by Genworth units - acquired by AXA in 2015 - and sold through GE Capital Bank, a business later purchased by Santander in 2009. At the heart of the matter were more than 650,000 customer complaints concerning PPI products, which have become emblematic of Britain’s most costly retail financial scandal, with total industry compensation surpassing £40 billion.
AXA initiated proceedings in 2021, arguing that it had inherited not just the underwriting obligations but also significant liabilities when it took on the Genworth businesses. The court heard that AXA had disbursed nearly £500 million in consumer redress and incurred a further £70 million in ombudsman-related costs. Mr Justice Julia Dias concluded that AXA was entitled to seek indemnification from Santander Insurance Services UK Ltd for these payments.
The judge held that AXA had a valid claim for redress under the existing agreements. AXA’s legal team, led by Quinn Emanuel, stated the ruling was worth approximately £675 million. However, an AXA spokesperson acknowledged that the group would only receive a portion of that sum, as Genworth had already reimbursed part of the exposure under a separate arrangement.
Santander has signalled its intention to appeal. A spokesperson for the Spanish banking giant said: “We disagree with the outcome and are seeking to appeal. We do not expect the net impact of the judgment to be material for Santander given provisions already made and the potential legal actions available.
“No customers have suffered loss as a consequence of the claim brought by AXA France or the judgment, nor does it impact upon past redress paid to customers for PPI complaints.”
The judgment marks a significant moment in a case that has been closely watched by financial institutions and insurers alike, particularly given its implications for legacy liabilities in large-scale acquisitions.
While AXA was the named claimant, Genworth - whose former units gave rise to the original obligations - has indicated that it stands to benefit under its agreement with AXA. In a statement, the US-based financial group said it anticipates recovering around $750 million (approximately £560 million) from AXA if the ruling is upheld and payments are made in full.
Genworth stated that the funds would be directed towards strategic priorities, including its CareScout business, share repurchases, and debt reduction. Notably, it had not included any recovery in its forward capital planning, suggesting any windfall would be supplementary.
Earlier phases of the litigation also saw Santander attempt to strike out portions of AXA’s claim, arguing that a prior settlement had not been formally concluded. At a 2022 hearing, the bank contended that AXA had acted inconsistently by first conceding that no binding agreement existed, then later asserting that one had been reached “in conduct if not in writing”.
That argument was rejected by the High Court, which instead opted to resolve the matter at full trial, ultimately finding in favour of AXA.
This judgment will likely resonate across the insurance and banking sectors, underscoring the risks that can emerge from legacy product portfolios acquired during corporate restructurings. It also highlights the significance of post-acquisition indemnity frameworks and the importance of rigorously assessing long-tail liability exposures.
For AXA, the ruling offers a measure of vindication following years of litigation and a reminder of the enduring financial fallout from the UK’s PPI debacle. For Santander, it raises fresh questions about the due diligence undertaken in its acquisition of GE Capital’s UK operations - and the potential scope of exposure that may yet emerge from Britain’s most controversial financial product.
